Atypical inflammation in the central nervous system in prion disease

Current Opinion in Neurology

Volumn 15, Issue 3, 2002, Pages 349-354

  Perry, V Hugh ^a   Cunningham, Colm ^a   Boche, Delphine ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; PROSTAGLANDIN E2; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

CELL ACTIVATION; CENTRAL NERVOUS SYSTEM; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; HUMAN; IMMUNOCYTOCHEMISTRY; INFLAMMATION; MICROGLIA; PHAGOCYTOSIS; PRION DISEASE; REVIEW;

ANIMALS; CENTRAL NERVOUS SYSTEM; CYTOKINES; DINOPROSTONE; ENCEPHALITIS; HUMANS; MICROGLIA; PRION DISEASES; REACTIVE OXYGEN SPECIES; TRANSFORMING GROWTH FACTOR BETA;

EID: 0036267207     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-200206000-00020     Document Type: Review

References (65)

1. The prion diseases
2. Inflammation in Alzheimer's disease: A view from the periphery
3. A crucial role for B cells in neuroinvasive scrapie
4. PrP protein is associated with follicular dendritic cells of spleens and lymph nodes in uninfected and scrapie-infected mice
5. Characterization of the microglial response in murine scrapie
6. Evidence for an early inflammatory response in the central nervous system of mice with scrapie
7. Evolution of a strain of CJD that induces BSE-like plaques
8. Immunohistochemical study of microglia in the Creutzfeldt-Jakob diseased brain
9. Reactive microglia in Creutzfeldt-Jakob disease
10. Role of microglia in neuronal cell death in prion disease
11. Microglial activation varies in different models of Creutzfeldt-Jakob disease
12. Early behavioural changes in scrapie-affected mice and the influence of dapsone
13. Microglia: A sensor for pathological events in the CNS
14. Synapse loss associated with abnormal PrP precedes neuronal degeneration in the scrapie-infected murine hippocampus
15. Neurotoxicity of a prion protein fragment
16. Role of microglia and host prion protein in neurotoxicity of a prion protein fragment
17. Killing of prion-damaged neurones by microglia
18. Microglial cells respond to amyloidogenic PrP peptide by the production of inflammatory cytokines
19. The cellular prion protein binds copper in vivo
20. Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity
21. Prion infection impairs the cellular response to oxidative stress
22. In vivo cytotoxicity of the prion protein fragment 106-126
23. The acute inflammatory response in CNS following injection of prion brain homogenate or normal brain homogenate
24. 2 and lipocortin-1 in the CNS during the incubation period of murine scrapie correlates with progressive PrP accumulations
25. Activation of cerebral cytokine gene expression and its correlation with onset of reactive astrocyte and acute-phase response gene expression in scrapie
26. Heightened expression of tumor necrosis factor alpha, interleukin 1 alpha, and glial fibrillary acidic protein in experimental Creutzfeldt-Jakob disease in mice
27. Expression of cytokine genes and increased nuclear factor-kappa B activity in the brains of scrapie-infected mice
28. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10
29. Absence of detectable IL-1 beta production in murine prion disease: A model of chronic neurodegeneration
30. Transforming growth factor β1 (TGFβ1), the dominant cytokine in murine prion disease: Influence on inflammatory cytokine synthesis and alteration of vascular extracellular matrix
31. Tumor necrosis factor alpha-deficient, but not interleukin-6-deficient, mice resist peripheral infection with scrapie
32. Differential expression of transforming growth factor-beta isoforms in human prion diseases
33. Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-beta 1
34. Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease
35. Chronic overproduction of transforming growth factor-beta1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice
36. Cyclooxygenase-2 is highly expressed in microglial-like cells in a murine model of prion disease
37. Increased brain synthesis of prostaglandin E2 and F2-isoprostane in human and experimental transmissible spongiform encephalopathies
38. Cytokines, prostaglandins and lipocortin-1 are present in the brains of scrapie-infected mice
39. Interferon gamma and prostaglandin in BSE-infected cattle
40. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF
41. Anti-inflammatory effects of prostaglandin E2 in the central nervous system in response to brain injury and circulating lipopolysaccharide
42. Alteration of free radical metabolism in the brain of mice infected with scrapie agent
43. Mitochondrial dysfunction induced by oxidative stress in the brains of hamsters infected with the 263 K scrapie agent
44. Transcriptional and translational regulation of inflammatory mediator production by endogenous TGF-beta in macrophages that have ingested apoptotic cells
45. PrP deposition, microglial activation, and neuronal apoptosis in murine scrapie
46. Neuronal cell death in scrapie-infected mice is due to apoptosis
47. Apoptosis and dendritic dysfunction precede prion protein accumulation in 87V scrapie
48. An 85-kb tandem triplication in the slow Wallerian degeneration (Wlds) mouse
49. Compartmental neurodegeneration and synaptic plasticity in the Wld(s) mutant mouse
50. Role of spleen macrophages in the clearance of scrapie agent early in pathogenesis
51. The CNS acute inflammatory response to excitotoxic neuronal cell death
52. Microglia and macrophages are the major source of tumor necrosis factor in permanent middle cerebral artery occlusion in mice
53. Inflammation and Alzheimer's disease
54. Cause of death in Alzheimer's disease
55. An essential role of interleukin-1beta in mediating NF-kappaB activity and COX-2 transcription in cells of the blood-brain barrier in response to a systemic and localized inflammation but not during endotoxemia
56. Endogenous brain IL-1 mediates LPS-induced anorexia and hypothalamic cytokine expression
57. Molecular basis of sickness behavior
58. Cytokines and acute neurodegeneration
59. Acceleration of scrapie disease in mice by an adenovirus
60. Dapsone to delay symptoms in Creutzfeldt-Jakob disease
61. Alzheimer's disease and Creutzfeldt-Jakob disease: Overlap of pathogenic mechanisms
62. Alzheimer disease and the prion disorders amyloid beta-protein and prion protein amyloidoses
63. Brain inflammation in Alzheimer disease and the therapeutic implications
64. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease
65. Peripheral infection evokes exaggerated sickness behaviour in pre-clinical murine prion disease